This kit uses RT-PCR for in vitro detection of Haemophilus influenzae in nasopharyngeal and/or oropharyngeal swabs, sputum, bronchoalveolar lavage fluid, serum, and plasma samples. Test results may serve as a reference for clinical evaluation of Haemophilus influenzae infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
Only one step for nucleic acid processing, reducing operations to direct PCR sample processing and amplification. Turnaround time is less than 35 minutes.